Navigation Links
MultiCell and University Health Network Will Evaluate Two Potential Therapies for Liver Cancer Treatment
Date:7/11/2011

WOONSOCKET, R.I., July 11, 2011 /PRNewswire/ -- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) ("MultiCell") today announced that it entered into a sponsored research agreement with University Health Network pursuant to which Anand Ghanekar, M.D., Ph.D., of the University Health Network's Toronto General Hospital, will direct research activities relating to the evaluation of MultiCell's product candidates MCT-465 and MCT-485, in in vitro models for the treatment of primary liver cancer.  The mechanism of action of MCT-465 and MCT-485 and their potential selective effect on liver cancer stem cells will also be evaluated.  

The role of liver stem cells in the carcinogenic process has led researchers to hypothesize that primary liver cancer arises by maturation arrest of liver stem cells.  While progress has been made in developing cancer therapies that result in cytoreduction, the control of cancer over a longer interval and especially of metastatic disease remains a key goal.  Cancer stem cells are believed to be responsible for cancer relapse by being less sensitive to conventional therapies.  MultiCell owns exclusive rights to several issued U.S. patents and corresponding foreign patents related to the isolation and differentiation of liver stem cells.  

Primary liver cancer resulting from Hepatitis B and Hepatitis C infection is the most common cancer in the world with more than 1 million new cases diagnosed each year.  Primary liver cancer is rarely discovered early and often does not respond to treatment.

"We are pleased to have the opportunity to work with Dr. Ghanekar and his colleagues at Toronto General Hospital," said W. Gerald Newmin, Chairman and Chief Executive Officer of MultiCell.  "Dr. Ghanekar is one of the leading researchers in the field of liver cancer, and we are hopeful MCT-465 and MCT-
'/>"/>

SOURCE MultiCell Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MultiCell Technologies Signs Liver Stem Cell R&D Agreement To Develop Products for the Study of Liver Cancer
2. MultiCell Technologies is Granted U.S. Patent for Immortalized Human Liver Cell Lines
3. MultiCell Technologies Is Granted European Patent for the Treatment of Cancer
4. MultiCell Hires Clinical Research Organization to Manage MCT-125 Phase IIb Clinical Trial
5. MultiCell Technologies Launches New Web Site
6. MultiCells Majority Owned Subsidiary Acquires Bioabsorbable Interventional Cardiology Stent Assets
7. MultiCell Technologies is Granted Stem Cell Patent
8. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
9. Boston University Biomedical Engineers Find Chink in Bacterias Armor
10. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
11. Potential Breakthrough Cancer Treatment Emerges from MIPS-Funded Clinical Trial Teaming CSA Medical Inc. and University of Maryland Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... DUBLIN , Aug. 19, 2014 ... the "Pharmaceutical Contract Manufacturing - Global Strategic Business ... This report analyzes the worldwide markets for Pharmaceutical Contract ... Injectables (Injections, Vials, and IV solutions), Solid Dosage Forms ... (Syrups, Suspensions, Gels, Creams & Ointments). The ...
(Date:8/19/2014)... , Aug. 19, 2014 Research and Markets ... by Type of Material, by Technology, by Application & by ... their offering. The demand for membranes is ... driving the market to $29.31 billion Membrane technology ... applications, such as water filtration and kidney dialysis. In modern ...
(Date:8/19/2014)... According to Kalorama Information, electronic medical records ... Data in healthcare a reality, and this a factor ... American Recovery and Reinvestment Act, the U.S. government dedicated ... penalties will start applying soon for use of paper ... study of the EMR industry, EMR 2014: The ...
Breaking Medicine Technology:Global Pharmaceutical Contract Manufacturing - Strategic Business Report 2014 2Global Membranes (MF, RO, UF, Gas Separation, Dialysis, NF) Market - Forecasts to 2019 2Kalorama: EMR Paves the Way for Big Data 2Kalorama: EMR Paves the Way for Big Data 3
(Date:8/19/2014)... in multitasking and ways to train it have been ... universitaire de griatrie de Montral and the University of ... the effectiveness of this training. Cooking while having a ... driving while listening to a radio show ... Unfortunately, it decreases with age, which makes it harder ...
(Date:8/19/2014)... August 20, 2014 Recently, iFitDress.com,a leading ... outfits, has unveiled its new collection of pewter ... to expand the company’s global market. Each item is ... the company’s senior spokesman, customers that have specific requirements ... iFitDress.com. Now, all the brand new items are offered ...
(Date:8/19/2014)... -- Lupus and other rheumatic diseases can cause ... can delay a correct diagnosis for months, a ... can also cause these types of symptoms, according ... in Maywood, Ill. Rheumatic disorders include autoimmune and ... such as lupus, systemic vasculitis and ankylosing spondylitis. ...
(Date:8/19/2014)... from Glasgow where he helped distribute thousands of The ... 23 – August 6), Pete Dwan is a man with ... for his work cannot be overstated. , According to UK ... A drugs within the last year. And that doesn’t take ... to be “legal highs” until June 2014, when the UK ...
(Date:8/19/2014)... the longtime standard treatment for atrial fibrillation, is ... drug marketplace including dabigatran, rivaroxaban, and apixaban. A ... novel oral anticoagulants (NOACs) into clinical practice. By ... anticoagulant prescriptions yet this represents 98% of total ... The American Journal of Medicine . , Atrial ...
Breaking Medicine News(10 mins):Health News:Targeted brain training may help you multitask better 2Health News:Discounted Pewter Evening Dresses For 2014 Unveiled By Company iFitDress.com 2Health News:Certain Symptoms Can Delay Lupus Diagnosis, Researchers Report 2Health News:British Scientologist on a Mission to Save Youth from Drug Abuse 2Health News:Novel oral anticoagulant prescriptions soar, but at a high cost 2Health News:Novel oral anticoagulant prescriptions soar, but at a high cost 3
... Oct. 15 Impelsys , a global ... American Academy of Pediatrics (AAP), a ... solidified its e-book strategy with iPublishCentral , ... 350 publishers worldwide. Launching in early 2010, AAP will ...
... DEERFIELD, Ill., October 14, 2009 A study, published ... showed that a greater percentage of patients with type ... (pioglitazone HCl and metformin HCl) as initial therapy reached ... percent compared to either component alone. Safety and tolerability ...
... at reducing the risk of heart attacks and heart ... new report from the Institute of Medicine. The ... secondhand smoke boosts nonsmokers, risk for heart problems, adding ... could lead to a heart attack is compelling. ...
... Program Seeks Adult Athletes to Go the Extra Mile to ... Teen and pre-teen girls face peer pressure, cultural stereotypes ... impact on their futures. That is why former Ironman ... prevention program that prepares girls for a lifetime of self-respect ...
... DIEGO, Oct. 15 Cardium Therapeutics (NYSE Amex: CXM ... to selected investors for aggregate gross proceeds of $6.0 million. ... was filed by Cardium Therapeutics with the Securities and Exchange ... August 15, 2007. Details concerning the terms of the ...
... tradition of capturing celebrity in photograph with 2009 Christmas ... Lung Association has brought back a time-honored tradition this ... a photograph with the 2009 Christmas Seal. This ... distinguished list of celebrities and entertainers who have served ...
Cached Medicine News:Health News:Leading Society Publisher, American Academy of Pediatrics, Chooses iPublishCentral to Launch e-Book Strategy 2Health News:Leading Society Publisher, American Academy of Pediatrics, Chooses iPublishCentral to Launch e-Book Strategy 3Health News:New data showed type 2 diabetes patients experienced greater blood sugar reductions 2Health News:New data showed type 2 diabetes patients experienced greater blood sugar reductions 3Health News:New data showed type 2 diabetes patients experienced greater blood sugar reductions 4Health News:New data showed type 2 diabetes patients experienced greater blood sugar reductions 5Health News:Smoking bans reduce the risk of heart attacks associated with secondhand smoke 2Health News:Girls on the Run Inspires Girls to Recognize and Achieve Their Potential Through the Power of Running 2Health News:Girls on the Run Inspires Girls to Recognize and Achieve Their Potential Through the Power of Running 3Health News:Cardium Announces $6.0 Million Registered Direct Offering 2Health News:Cardium Announces $6.0 Million Registered Direct Offering 3Health News:S. Epatha Merkerson Lends Star Power to Support the American Lung Association's Christmas Seals Campaign as Celebrity Chairperson 2
... / Ker Accuref K 9001 ... LCD color monitor. 3 step ... 2.3 mm Minimum pupil diameter ... adjuster. Auto start function. Kerato-Peripheral ...
... Suresight is the child-friendly, portable ... children and adults. It can perform ... inches (35 cm) away even through ... flashing lights and sounds engage the ...
Neomycin and Polymyxin B sulfates and Dexamethasone ophthalmic ointment is a multiple dose anti-infective steroid combination in sterile ointment form for topical applications....
Optoelectronic stimulator, "ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Pattern stimulations for ERG and VEP, multifocal stimulations for ERG and VEP, complies with international...
Medicine Products: